Adaptation of a human gut epithelial model in relation to the assessment of clinical pharmacokinetic parameters for selected tyrosine kinase inhibitors. ADMET and DMPK, [S. l.], v. 3, n. 1, p. 51–67, 2015. DOI: 10.5599/admet.3.1.169. Disponível em: https://pub.iapchem.org/ojs/index.php/admet/article/view/169. Acesso em: 28 apr. 2026.